BioWorld MedTech

July 15, 2015

DragonBio's remaining stake worth $73 million: Mindray finishes what it started with acquisition of remaining stake in Dragonbio

HONG KONG — Chinese medical device maker, Mindray Medical (Shenzhen) will acquire for $72.6 million the remaining 49% stake in Dragonbio Surgical Implant (Wuhan, China) that it did not acquire in an earlier deal. Read More

Inside the Beltway: FDA applies revised USP standards to draft guidance for heparin-bearing products

European TechTour Summit: Med-tech becoming increasingly 'personal' as technology improves

Attitude Adjustment needed: Beltway attitude change needed to spur biomedical investment

New Trade Association: Association forms to help smaller device firms promote value-based solutions

Financings: Opgen closes $6M funding headed up by Merck GHI

World in Review: Danish cancer center first in Europe to use Varian's Calypso transponders

Agreements/contracts: Multiple company collaboration to fight Type 2 diabetes battle

Briefly Noted

Products

People in Places

MDD's Oncology Extra

Today's news in brief

BioWorld

BioWorld briefs for Feb. 9, 2025.

MJFF grant supports Bexorg’s translational biomarker work

BioWorld Science

Bexorg Inc. has been awarded a research grant from The Michael J. Fox Foundation for Parkinson’s Research (MJFF) through the Targets to Therapies initiative to...

KLF15 shows potential as marker, target for cholangiocarcinoma

BioWorld Science

Researchers at the Biodonostia Health Research Institute reported on the role of KLF15 in cholangiocarcinogenesis and its potential as a therapeutic target in...

Illustration of SCAN in Parkinson’s vs healthy subcortex

SCAN is core circuit affected in Parkinson’s disease

BioWorld Science

Parkinson’s disease (PD) is a neurodegenerative disorder that affects movement, and tremor is one of its signatures. But it is a much more wide-ranging disorder,...

Astellas’ ASP-2246 shows promise in stroke management

BioWorld Science

Astellas Pharma Inc. recently presented data regarding ASP-2246, a drug candidate comprised of an mRNA encoding the transcription factor NeuroD1 encapsulated in...